Steven O Connell, a seasoned business professional, has established a notable career in the biotechnology industry, with specialties in molecular biology, synthetic biology, and bioprocessing. As the Operations Lead and Company Director at Pear Bio, he supervises the utilisation of cutting-edge organ-on-a-chip technology to reimagine, visualise, and compute the human tumour microenvironment's impact on cancer progression. Steven has collaborated closely with over 60 early-stage biotech and health tech companies, being passionate about bridging the gap between startups, investors, officials, and corporates. He also has an MSc in Biotechnology and Business to supplement his knowledge of both business and scientific domains.

Frequently lending his proficiency, he has facilitated over 50 strategic collaborations in multiple industries to provide extra business resources, investment support, and scientific know-how to biotechnology firms. In the course of the last five years, he has established an international community of key players in the life sciences, leveraging support and opening new opportunities for his initiatives.